SE437374B - Analogiforfarande for framstellning av 8-(1h-tetrazol-5-yl)-11h-pyrido/2,1-b/kinazolin-11-oner - Google Patents
Analogiforfarande for framstellning av 8-(1h-tetrazol-5-yl)-11h-pyrido/2,1-b/kinazolin-11-onerInfo
- Publication number
- SE437374B SE437374B SE7712308A SE7712308A SE437374B SE 437374 B SE437374 B SE 437374B SE 7712308 A SE7712308 A SE 7712308A SE 7712308 A SE7712308 A SE 7712308A SE 437374 B SE437374 B SE 437374B
- Authority
- SE
- Sweden
- Prior art keywords
- pyrido
- tetrazol
- zmu
- preparation
- chinazolin
- Prior art date
Links
- -1 1H-TETRAZOL-5-YL Chemical class 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 6
- ZIJAZUBWHAZHPL-UHFFFAOYSA-N 6-chloropyridine-3-carboxamide Chemical compound NC(=O)C1=CC=C(Cl)N=C1 ZIJAZUBWHAZHPL-UHFFFAOYSA-N 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- GTTYPHLDORACJW-UHFFFAOYSA-N nitric acid;sodium Chemical compound [Na].O[N+]([O-])=O GTTYPHLDORACJW-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 2
- 150000003246 quinazolines Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- UMKSAURFQFUULT-UHFFFAOYSA-N 2-Amino-5-methoxybenzoic acid Chemical compound COC1=CC=C(N)C(C(O)=O)=C1 UMKSAURFQFUULT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 206010027654 Allergic conditions Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/737,878 US4066767A (en) | 1976-11-01 | 1976-11-01 | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7712308L SE7712308L (sv) | 1978-05-02 |
| SE437374B true SE437374B (sv) | 1985-02-25 |
Family
ID=24965667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7712308A SE437374B (sv) | 1976-11-01 | 1977-11-01 | Analogiforfarande for framstellning av 8-(1h-tetrazol-5-yl)-11h-pyrido/2,1-b/kinazolin-11-oner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4066767A (cs) |
| JP (1) | JPS5356699A (cs) |
| AU (1) | AU515283B2 (cs) |
| BE (1) | BE860319A (cs) |
| CA (1) | CA1197844A (cs) |
| CH (1) | CH638205A5 (cs) |
| DE (1) | DE2742708C2 (cs) |
| DK (1) | DK143403C (cs) |
| ES (1) | ES463092A1 (cs) |
| FR (1) | FR2369279A1 (cs) |
| IE (1) | IE46258B1 (cs) |
| LU (1) | LU78415A1 (cs) |
| NL (1) | NL7711969A (cs) |
| SE (1) | SE437374B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| US4348396A (en) * | 1978-01-23 | 1982-09-07 | Hoffmann-La Roche Inc. | Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them |
| DE2845766A1 (de) * | 1978-10-18 | 1980-04-30 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
| ES8406476A1 (es) * | 1982-04-29 | 1984-07-01 | Erba Farmitalia | Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas. |
| US4551460A (en) * | 1982-05-10 | 1985-11-05 | Hoffmann-La Roche Inc. | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis |
| ES8501397A1 (es) * | 1982-08-05 | 1984-11-16 | Erba Farmitalia | "procedimiento para preparar derivados de quinazolina" |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3982000A (en) * | 1973-01-19 | 1976-09-21 | Sandoz, Inc. | Alkyl-substituted-tricyclic quinazolinones as bronchodilators |
| US3966965A (en) * | 1973-03-23 | 1976-06-29 | American Home Products Corporation | Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions |
| US4012387A (en) * | 1975-09-18 | 1977-03-15 | Warner-Lambert Company | Benzo-[g]pyrido[2,1-b]quinazolinones |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
-
1976
- 1976-11-01 US US05/737,878 patent/US4066767A/en not_active Expired - Lifetime
-
1977
- 1977-09-22 IE IE1939/77A patent/IE46258B1/en unknown
- 1977-09-22 DE DE2742708A patent/DE2742708C2/de not_active Expired
- 1977-09-26 AU AU29126/77A patent/AU515283B2/en not_active Expired
- 1977-10-10 ES ES77463092A patent/ES463092A1/es not_active Expired
- 1977-10-24 CA CA000289376A patent/CA1197844A/en not_active Expired
- 1977-10-26 FR FR7732215A patent/FR2369279A1/fr active Granted
- 1977-10-28 LU LU78415A patent/LU78415A1/xx unknown
- 1977-10-28 BE BE6046198A patent/BE860319A/xx not_active IP Right Cessation
- 1977-10-31 DK DK482877A patent/DK143403C/da not_active IP Right Cessation
- 1977-10-31 NL NL7711969A patent/NL7711969A/xx not_active Application Discontinuation
- 1977-10-31 JP JP12979377A patent/JPS5356699A/ja active Pending
- 1977-11-01 CH CH1331677A patent/CH638205A5/de not_active IP Right Cessation
- 1977-11-01 SE SE7712308A patent/SE437374B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE46258L (en) | 1978-05-01 |
| LU78415A1 (cs) | 1978-01-31 |
| AU2912677A (en) | 1979-04-05 |
| ES463092A1 (es) | 1978-12-01 |
| NL7711969A (nl) | 1978-05-03 |
| JPS5356699A (en) | 1978-05-23 |
| CH638205A5 (de) | 1983-09-15 |
| IE46258B1 (en) | 1983-04-20 |
| DK482877A (da) | 1978-05-02 |
| SE7712308L (sv) | 1978-05-02 |
| DK143403B (da) | 1981-08-17 |
| DE2742708C2 (de) | 1982-04-22 |
| FR2369279A1 (fr) | 1978-05-26 |
| DK143403C (da) | 1981-12-21 |
| AU515283B2 (en) | 1981-03-26 |
| BE860319A (fr) | 1978-04-28 |
| US4066767A (en) | 1978-01-03 |
| DE2742708A1 (de) | 1978-05-03 |
| CA1197844A (en) | 1985-12-10 |
| FR2369279B1 (cs) | 1981-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS221288B2 (en) | Method of making the heterocyclic compounds | |
| SU999972A3 (ru) | Способ получени производных пиридо-(1,2-а) пиримидина или их фармацевтически приемлемых солей,или их оптически активных изомеров | |
| US4284768A (en) | 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives | |
| SE436357B (sv) | Forfarande for framstellning av pyrimido/6,1-a/isokinolin-4-on-derivat | |
| EP0230334B1 (en) | A indenothiazole derivative and process for preparing the same | |
| SE437374B (sv) | Analogiforfarande for framstellning av 8-(1h-tetrazol-5-yl)-11h-pyrido/2,1-b/kinazolin-11-oner | |
| Dewar | 167. Attempts to find new antimalarials. Part XXI | |
| EP0118913A2 (en) | Porphyrin derivatives | |
| US3843663A (en) | 1,8-naphthyridine compounds | |
| JPH0573753B2 (cs) | ||
| CN109153652B (zh) | 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮的制备工艺 | |
| Hari Narayana Moorthy et al. | Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo [a] phenazine-5-sulfonic acid derivatives | |
| US4124587A (en) | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones | |
| US3901889A (en) | 1,2-bis-(4-phenyl-1-piperazinyl)-ethanes | |
| JPS5988472A (ja) | オキシイミノ化合物およびその製造法 | |
| US4575553A (en) | Antitumor m-AMSA analog | |
| Richter et al. | The Reaction between 4-Nitroquinoline 1-Oxide and Diethyl Sodiomalonate. An Unexpected Nucleophilic Substitution1 | |
| SE434748B (sv) | 3-(tetrazol-5-yl)-1-azaxautoner | |
| US3113948A (en) | 2-(alpha-oxo aralkyl) benzimidazole compounds, and process of making same | |
| Gilman et al. | Some Methylquinolines Patterned as “Open Models” of Atebrin | |
| CN112174958A (zh) | 一种吡啶并[2,3-d]嘧啶类化合物及其制备方法和用途 | |
| US4599409A (en) | Bisamidine derivatives of 5,10-dioxo-4,5,9,10-tetrahydro-4,9-dioxopyrenes, of 6(5H)-phenanthridones, and of phenanthridines, useful as chemotherapeutic agents | |
| CA1156230A (en) | 1-substituted-6-n-propyl-8-methylimidazo¬1,5-d|- as-triazin-4(3h)-ones | |
| US4757080A (en) | 1,4-dihydropyridine derivatives | |
| US3129216A (en) | S-basic substituted-s-dibenso-fb |